跳至主要内容
临床试验/CTRI/2023/08/056801
CTRI/2023/08/056801尚未招募4 期

A Comparative Study of High Dose Atorvastatin and Rosuvastatin in Prevention of Contrast Induced Nephropathy in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty - NI

Sreeja Nittoori0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either gender aged between 18 and 70 years 2. Patients on stable dose of statins 3. Patients posted for PTCA requiring = 100ml contrast

排除标准

  • 1. Patients with high-risk features like cardiogenic shock, acute pulmonary edema and bleeding complications 2. ESRD requiring dialysis 3. Patients who have received intravenous contrast in the last 2 weeks 4. contraindications to statin treatment 5. patients on concomitant use of potential nephrotoxic agents 6. pregnancy and lactating women

研究者

发起方
Sreeja Nittoori

相似试验